TAIWAN · TWSE / TPEx
Intech
益得 · 6461 · TPEx (OTC) · Biotech and medical
Share price, 2026-10-19NT$28.601 month +16.3% · 1 year -1.2%
Directors and supervisors hold51,957,17247.1% of shares issued
Of which pledged0.0%0
Major shareholders (10%+) hold47,055,21042.7% of shares issued
Revenue, 2026-09+18.1%year on year
Share price, last 12 months
Daily closes adjusted for cash and stock dividends, against the TAIEX index rebased to the same start. Prices from Yahoo Finance.
Directors, officers and major shareholders
Holdings reported for 2026-09. At election = shares held when the director was elected. Related parties = holdings of the person's spouse, minor children and nominees. One person with two roles is listed once.
| Person | Role | At election | Now | Of the company | Pledged | Related parties |
|---|---|---|---|---|---|---|
| 健喬信元醫藥生技股份有限公司 | Chairman · Director · Major shareholder (10%+) | 76,069,971 | 47,055,210 | 42.65% | — | — |
| 林智暉 | Chairman (corporate representative) | — | 739,594 | 0.67% | — | 19,328 |
| 廖尤里 | Director (corporate representative) | — | 8,423 | 0.01% | — | — |
| 楊勝仁 | Director (corporate representative) | — | 0 | — | — | — |
| 行政院國家發展基金管理會 | Director | 7,379,569 | 4,564,839 | 4.14% | — | — |
| 黃奇英 | Director (corporate representative) | — | 0 | — | — | — |
| 聯捷投資股份有限公司 | Director | 425,000 | 262,895 | 0.24% | — | — |
| 王子博 | Director (corporate representative) | — | 0 | — | — | — |
| 戴昇功 | Director | — | 6,185 | 0.01% | — | 6,185 |
| 廖耀宗 | Independent director | — | 0 | — | — | — |
| 林秀美 | Independent director | 110,000 | 68,043 | 0.06% | — | — |
| 黃炳勳 | Independent director | — | 0 | — | — | — |
| CHAWLA MANISH | President · Other | — | 61,857 | 0.06% | — | — |
| 皮先智 | Assistant vice president | — | 202,276 | 0.18% | — | — |
| 陳淑慧 | Chief accountant · Other | — | 7,422 | 0.01% | — | — |